5 insiders reported 8 Form 4 transactions for Allarity Therapeutics, Inc. (ALLR) over the past 18 months (most recent 2026-05-14). Recent activity: Jensen Thomas (CEO) Buy 200,000 shares, Hoeiland Jesper (Director) Buy 25,000 shares, McLaughlin Gerald W. (Director) Buy 45,000 shares, Graff Jeremy R. (President and Chief Development Officer) Buy 133,333 shares, Ervin Jeffrey S (CFO) Buy 150,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | Jensen Thomas | CEO | Buy | 200,000 | $0 |
| 2026-05-11 | Hoeiland Jesper | Director | Buy | 25,000 | $0 |
| 2026-05-07 | McLaughlin Gerald W. | Director | Buy | 45,000 | $0 |
| 2026-04-30 | Graff Jeremy R. | President and Chief Development Officer | Buy | 133,333 | $0 |
| 2026-04-30 | Ervin Jeffrey S | CFO | Buy | 150,000 | $0 |
| 2026-01-16 | Graff Jeremy R. | President and Chief Development Officer | Buy | 133,333 | $0 |
| 2025-10-02 | Graff Jeremy R. | President and Chief Development Officer | Buy | 39,494 | $0 |
| 2025-10-02 | Graff Jeremy R. | President and Chief Development Officer | Sell | 14,613 | $23,089 |
Source: SEC Form 4 filings · as of 2026-05-14